RCUS FY 2019 Earnings — Arcus Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

RCUSArcus Biosciences, Inc.

$2B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$15M+79.6% YoY

Gross Profit

$15M100.0% margin

Operating Income

-$89M-591.4% margin

Net Income

-$85M-564.7% margin

EPS (Diluted)

$-1.73

Cash Flow

Operating Cash Flow

-$73M

Free Cash Flow

-$75M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$203M

Total Liabilities

$39M

Stockholders' Equity

$164M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$8M	+79.6%
Gross Profit	$15M	$8M	+79.6%
Operating Income	-$89M	-$55M	-61.7%
Net Income	-$85M	-$50M	-70.8%